EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cerebral ischemia-reperfusion injury: mechanisms and promising therapies

Mingming Yang, Boya Liu, Bingqian Chen, Yuntian Shen, Guangliang Liu

Frontiers in Pharmacology · 16.07.2025 · 16

DOI: 10.3389/fphar.2025.1613464 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 16.07.2025. Verfasst von Mingming Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Binhai County People's Hospital, Yancheng, Jiangsu, China. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral ischemia-reperfusion injury (Cerebral I/R injury) is a critical pathological process following ischemic stroke, closely associated with multiple mechanisms including oxidative stress, neuroinflammation, and neuronal apoptosis. It also involves the alteration and regulation of numerous key genes and non-coding RNAs. Due to its complex regulatory mechanisms, there are currently no Food and Drug Administration (FDA)-approved drugs specifically targeting Cerebral I/R injury. Developing effective therapeutic strategies for Cerebral I/R injury remains a significant challenge in medical research. This review summarizes current treatment approaches for Cerebral I/R injury, which include traditional drugs, antioxidants, neuroprotective agents, exosomes, noncoding RNA therapeutics and combined intervention therapy. Pharmacotherapies exert positive effects on Cerebral I/R injury through antioxidative, anti-inflammatory, and neuroprotective mechanisms. Exosomes and noncoding RNA therapeutics can mitigate brain cell damage and promote neural function recovery by regulating the expression of downstream key genes via miRNAs, demonstrating potential as novel therapeutic options. Emerging evidence indicates that combined therapeutic strategies incorporating nanoparticle-mediated targeting demonstrate efficacy in treating cerebral I/R injury. By exploring the mechanisms of action and clinical application prospects of these different treatment strategies, this review aims to provide new insights and methods for the clinical management of Cerebral I/R injury.

Schlagwörter

Stichwörter der Autor:innen

antioxidantscerebral ischemia-reperfusion injuryexosomesneuroprotectionnon-coding RNAtraditional drugs

Autor:innen und Institutionen

  • Department of Pediatrics, Binhai County People's Hospital, Yancheng, Jiangsu, China.
  • Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Nantong Uni…
  • Department of Orthopaedics, Changshu Hospital Affiliated to Soochow University, First Peoples' Hospital of Changshu City, Changshu, Jiangsu, China.

Zitieren

APA

Yang, M., Liu, B., Chen, B., Shen, Y., & Liu, G. (2025). Cerebral ischemia-reperfusion injury: mechanisms and promising therapies. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1613464

Vancouver

Yang M, Liu B, Chen B, Shen Y, Liu G. Cerebral ischemia-reperfusion injury: mechanisms and promising therapies. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1613464

BibTeX
@article{Yang2025,
  author = {Yang, Mingming and Liu, Boya and Chen, Bingqian and Shen, Yuntian and Liu, Guangliang},
  title = {Cerebral ischemia-reperfusion injury: mechanisms and promising therapies},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1613464}
}
Kostenlos starten →